Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Elemento Lab
Explore this Website
Home
Affiliations
Research
Toggle Research menu options
Big Data Analytics & Machine Learning
Cancer Genomics
Drug Discovery
Epigenomics
Genetics
Mathematical Modeling
Projects
Proteomics
Spatial Computing
Software
Lab Team
Publications
News
Join Us
Weill Cornell Medicine
Care
Discover
Teach
Home
Affiliations
Research
Lab Team
Publications
News
Join Us
Home
Publications
Publications
Found 8 results
Author
Title
Type
Year
Filters:
Author
is
Zarnegar, Rasa
[Clear All Filters]
2012
Keutgen XM
,
Buitrago D
,
Filicori F
,
Kundel A
,
Elemento O
,
Fahey TJ
,
Zarnegar R
. 2012.
Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database.
.
Ann Surg. 255(5):981-5.
Keutgen XM
,
Filicori F
,
Crowley MJ
,
Wang Y
,
Scognamiglio T
,
Hoda R
,
Buitrago D
,
Cooper D
,
Zeiger MA
,
Zarnegar R
et al.
. 2012.
A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
.
Clin Cancer Res. 18(7):2032-8.
2014
Erler P
,
Keutgen XM
,
Crowley MJ
,
Zetoune T
,
Kundel A
,
Kleiman D
,
Beninato T
,
Scognamiglio T
,
Elemento O
,
Zarnegar R
et al.
. 2014.
Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.
.
Surgery. 156(6):1342-50;discussion1350.
Kleiman DA
,
Beninato T
,
Sultan S
,
Crowley MJP
,
Finnerty B
,
Kumar R
,
Panarelli NC
,
Liu Y-F
,
Lieberman MD
,
Seandel M
et al.
. 2014.
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors.
.
Ann Surg Oncol. 21 Suppl 4:S672-9.
2016
Crowley MJP
,
Scognamiglio T
,
Liu Y-F
,
Kleiman DA
,
Beninato T
,
Aronova A
,
Liu H
,
Jhanwar YS
,
Molina A
,
Tagawa ST
et al.
. 2016.
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
.
J Clin Endocrinol Metab. 101(3):981-7.
2018
Li W
,
Xia S
,
Aronova A
,
Min IM
,
Verma A
,
Scognamiglio T
,
Gray KD
,
Ullmann TM
,
Liang H
,
Moore MD
et al.
. 2018.
CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.
.
J Surg Oncol. 118(6):1042-1049.
Aronova A
,
Min IM
,
Crowley MJP
,
Panjwani SJ
,
Finnerty BM
,
Scognamiglio T
,
Liu Y-F
,
Whitsett TG
,
Garg S
,
Demeure MJ
et al.
. 2018.
STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
.
Ann Surg Oncol. 25(3):792-800.
2019
Finnerty BM
,
Moore MD
,
Verma A
,
Aronova A
,
Huang S
,
Edwards DP
,
Chen Z
,
Seandel M
,
Scognamiglio T
,
Du Y-CNancy
et al.
. 2019.
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
.
Endocr Relat Cancer. 26(4):411-423.